|
---|
Category:Legal-Pre-Filed Exhibits
MONTHYEARML18037A8842018-02-0606 February 2018 Nwmi Commission Hearing Exhibit List - Revision 2 ML18037A8822018-02-0606 February 2018 NWMI-012 - Northwest Medical Isotopes, LLC Responses to Commission'S Public Post-Hearing Questions ML18037B1162018-02-0606 February 2018 NRC-014 - NRC Staff Responses to Commission Post-Hearing Questions (Feb. 6, 2018) ML18016A9642018-01-23023 January 2018 NWMI-004-R - Northwest Medical Isotopes, LLC Presentation Slides: Overview Presentation ML18016A9592018-01-16016 January 2018 NWMI-001-R - Northwest Medical Isotopes, LLC Responses to Commission'S Public Pre-Hearing Questions ML18016A9622018-01-16016 January 2018 NWMI-003-R - Statement of Qualifications in Support of Northwest Medical Isotopes, LLC Medical Radioisotope Production Facility Construction Permit Application ML18016A9662018-01-16016 January 2018 NWMI-005-R - Northwest Medical Isotopes, LLC Presentation Slides: Safety 1 Presentation ML18016A9692018-01-16016 January 2018 NWMI-006-R - Northwest Medical Isotopes, LLC Presentation Slides: Safety 2 Presentation ML18016A9712018-01-16016 January 2018 NWMI-007-R - Northwest Medical Isotopes, LLC Presentation Slides: Environmental Presentation ML18016A9572018-01-16016 January 2018 Nwmi List of Anticipated Witnesses (Revision 1) - Final ML18016B0712018-01-16016 January 2018 NRC-002 - Draft Construction Permit for Northwest Medical Isotopes, LLC (Nov. 17, 2017) (ADAMS Accession No. ML17313A100) (Revised Jan. 16, 2018) ML18016B0722018-01-16016 January 2018 NRC-003 - Draft Summary Record of Decision, Construction Permit Application for the Northwest Medical Isotopes, LLC Radioisotope Production Facility (Nov. 17, 2017) (ADAMS Accession No. ML17313A338) (Revised Jan. 16, 2018) ML18016B0732018-01-16016 January 2018 NRC-004 - NRC Staff Revised Responses to Commission Pre-Hearing Questions (Jan. 16, 2018) (ADAMS Accession No. ML18016A554) ML18016B0742018-01-16016 January 2018 NRC-010 - Staff Presentation Slides - Overview (Jan. 16, 2018) ML18016B0752018-01-16016 January 2018 NRC-011 - Staff Presentation Slides - Safety Panel 1 (Jan. 16, 2018) ML18016B0762018-01-16016 January 2018 NRC-012 - Staff Presentation Slides - Safety Panel 2 (Jan. 16, 2018) ML18016B0772018-01-16016 January 2018 NRC-013 - Staff Presentation Slides - Environmental Panel (Jan. 16, 2018) ML18016A9552018-01-16016 January 2018 Nwmi Commission Hearing Exhibit-R List - Final ML18002A4192018-01-0202 January 2018 NRC Staff Witness List ML18001A0012018-01-0101 January 2018 Exhibit List (Revised) of Northwest Medical Isotopes, LLC ML17363A4172017-12-29029 December 2017 Northwest Medical Isotopes, LLC List of Anticipated Witnesses ML17363A4132017-12-29029 December 2017 NWMI-007 - Northwest Medical Isotopes, LLC Presentation Slides: Environmental Presentation ML17363A4122017-12-29029 December 2017 NWMI-006 - Northwest Medical Isotopes, LLC Presentation Slides: Safety 2 Presentation ML17363A4112017-12-29029 December 2017 NWMI-005 - Northwest Medical Isotopes, LLC Presentation Slides: Safety 1 Presentation ML17363A4102017-12-29029 December 2017 NWMI-004 - Northwest Medical Isotopes, LLC Presentation Slides: Overview Presentation ML17363A4092017-12-29029 December 2017 NWMI-003 - Statement of Qualifications in Support of Northwest Medical Isotopes, LLC Medical Radioisotope Production Facility Construction Permit Application ML17363A4082017-12-29029 December 2017 NWMI-001 - Northwest Medical Isotopes, LLC Responses to Commission'S Public Pre-Hearing Questions ML17363A2912017-12-29029 December 2017 Exhibit List of Northwest Medical Isotopes, LLC ML17363A4162017-12-18018 December 2017 NWMI-010 - Exemption Request Pursuant to 10 CFR 70.17, from Requirement of 10 CFR 70.21(f), Filing, for Northwest Medical Isotopes, LLC Radioisotope Production Facility, Dated December 18, 2017 ML17363A4142017-12-14014 December 2017 NWMI-008 - Federal, State of Missouri, City of Columbia, and Boone County Letters of Support for the Construction and Operation of the Northwest Medical Isotopes, LLC Radioisotope Production Facility ML18016B0982017-11-30030 November 2017 NRC-008 - Safety Evaluation Report Related to the Northwest Medical Isotopes, LLC Construction Permit Application for a Production Facility (Nov. 2017) (ADAMS Accession No. ML18016A021) (as Revised Jan. 2018) ML18016B0702017-11-16016 November 2017 NRC-001 - SECY-17-0116, Staff Statement in Support of the Uncontested Hearing for Issuance of a Construction Permit for the Northwest Medical Isotopes, LLC Production Facility (Nov. 16, 2017) (ADAMS Accession No. ML17313A037) ML18016B1092017-09-30030 September 2017 NRC-006B - Northwest Medical Isotopes, LLC, Construction Permit Application - Preliminary Safety Analysis Report (Psar), NWMI-2013-021, Rev. 3, Chapters 1 Through 2 (Sep. 2017) (ADAMS Accession Nos. ML17257A022 and ML17257A023) ML18016B1102017-09-30030 September 2017 NRC-006C - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapter 3 (Sep. 2017) (ADAMS Accession No. ML17257A024) ML18016B1142017-09-30030 September 2017 NRC-006D - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapter 4 (Sep. 2017) (ADAMS Accession No. ML17257A025) ML18016B1152017-09-30030 September 2017 NRC-006E - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapters 5 Through 10 (Sep. 2017) (ADAMS Accession Nos. ML17257A026, ML17257A027, ML17257A028, ML17257A029, ML17257A030, and ML17257A ML18016B1172017-09-30030 September 2017 NRC-006F - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapters 11 Through 12 (Sep. 2017) (ADAMS Accession Nos. ML17257A032 and ML17257A033) ML18016B1182017-09-30030 September 2017 NRC-006G - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapters 13 Through 18 (Sep. 2017) (ADAMS Accession Nos. ML17257A034, ML17257A035, ML17257A036, ML17257A037, ML17257A038, and ML17257 ML17363A4152017-09-15015 September 2017 NWMI-009 - Clean Water Act Section 401 Water Quality Certification of Northwest Medical Isotopes, LLC Facility in Boone County, NUREG-2209/CEK007189 ML18016B0992017-05-31031 May 2017 NRC-009 - NUREG-2209, Final Environmental Impact Statement for the Construction Permit for Northwest Medical Isotopes Radioisotope Production Facility (May 2017) (ADAMS Accession No. ML17130A862) ML18016B1192015-06-30030 June 2015 NRC-006H - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. Oa, Chapter 19, Beginning Through 19-130 (Jun. 2015) (ADAMS Accession Nos. ML15210A123 and ML15210A131) ML18016B1202015-06-30030 June 2015 NRC-006I - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. Oa, Chapter 19, 19-131 Through End (Jun. 2015) (ADAMS Accession Nos. ML15210A128 and ML15210A129) ML18016B1082015-02-15015 February 2015 NRC-006A - Northwest Medical Isotopes, LLC, Construction Permit Application - Cover Letter and General and Financial Information (Feb. 5, 2015) (ADAMS Accession Nos. ML15086A262 and ML15086A263 (in Part)) 2018-02-06
[Table view] |
Text
Exhibit NWMI-007-R U.S. Nuclear Regulatory Commission Commission Mandatory Meeting Environmental Panel January 23, 2018 11
Exhibit NWMI-007-R Development of Environmental Report Granted an exemption to submit the Construction Permit Application in two parts
[Published in Federal Register (FR) on October 24, 2013 (78 FR 63501)]
NRC conducted an independent evaluation of Part One of the Construction Permit Application and developed potential impacts of NWMIs proposed action Environmental Impact Statement Development Milestones
- NWMI submitted Part One of Construction Permit Application: February 5, 2015
- Environmental Site Audit/Scoping Meeting: December 8 & 9, 2015 (Columbia, MO)
- Draft EIS public comment period: November 1 - December 29, 2016 (Public meeting on December 6, 2016 in Columbia, Missouri)
- Final EIS published May 31, 2017 NUREG-2209, Final Environmental Impact Statement for the Construction Permit for the Northwest Medical Isotopes Radioisotope Production Facility (ADAMS Accession No. ML17130A862) 2
Exhibit NWMI-007-R Proposed Action Decide whether to issue a construction permit under 10 CFR 50 that would allow construction of the NWMI medical radioisotope production facility (RPF)
If a construction permit is granted by NRC, NWMI could build the proposed facility at the 3 hectare (7.4-acre) Discovery Ridge Research Park (Discovery Ridge) site, in Boone County, Columbia, Missouri NWMI RPF activities include:
- Fabricating low-enriched uranium (LEU) targets (including uranium recycle and recovery)
- Shipping targets to university research reactors
- Irradiating LEU targets at university research reactors
- Returning targets to RPF
- LEU target dissolution
- Molybdenum-99 (99Mo) recovery and purification 3
Exhibit NWMI-007-R Consultations Advisory Council on Historic Preservation Boone County Government Center City of Columbia, Missouri Mid-Missouri Regional Planning Commission Missouri Department of Conservation Missouri Department of Health and Senior Services Missouri Department of Natural Resources Missouri Department of Public Safety Missouri Department of Transportation U.S. Fish and Wildlife Service U.S. Department of Energy Tribal Nations 31 4
Exhibit NWMI-007-R Alternative Site Locations Evaluated by NWMI University of Missouri Research Reactor (MURR) - Columbia, MO Discovery Ridge Research Park - Columbia, MO Oregon State University (OSU) - Corvallis, OR McClellan Business Park (McClellan) - Davis, CA University of California at Davis (UC Davis) Research Reactor located at McClellan 5
Discovery Ridge Layout Exhibit NWMI-007-R RPF will be located on Lot 15 7.4-acre
- No existing structures
- Used for agriculture for past century NWMI anchor for radioisotope ecosystem; two existing companies 6
MURR RPF Layout Exhibit NWMI-007-R Preliminary RPF Layout Current MURR Layout 7
Exhibit NWMI-007-R Alternative Technologies/Alternatives Evaluated by NRC Alternative Technologies Alternatives Evaluated Neutron capture technology No-action alternative Aqueous homogenous reactor NWMI RPF at University of Missouri technology Research Reactor site (alternative site)
Selective gas extraction technology Linear accelerator-based facility at Discovery Ridge site (Alternative Uranium fission technology Technology No. 1)
Linear accelerator-based Subcritical fission-based facility at technology Discovery Ridge site (Alternative Technology No. 2) 8
Exhibit NWMI-007-R Connected Actions - University Research Reactor Washington State University Oregon State University Massachusetts Institute Of Technology University of Wisconsin University of MA Lowell Penn State University University of CA Davis LEGEND University of Missouri University Research Reactors Chosen University Research Reactors University of North Carolina Being Evaluated NWMI Radioisotope Production Facility University of Texas Texas A&M Prospective Transport Routes 9
Exhibit NWMI-007-R Connected Actions (continued)
Few facility modifications will be required No exterior construction anticipated for any reactor No changes in land use Minimal changes in staffing Authorization for possession and use of targets will be promulgated under the license amendment process for each facility
- MURR early 2018
- OSU early 2019 Third facility has been selected but not socialized 10
Exhibit NWMI-007-R Environmental Impact Summary Environmental Impact Summary Linear Accelerator-Based Subcritical Fission-Based NWMI RPF NWMI RPF Technology Technology at Discovery Ridge at MURR at Discovery Ridge at Discovery Ridge No Action Construction
- SMALL impacts to Impacts resource categories impacts to all resource resource categories resource categories all resource
- No historic properties categories
- No historic properties categories affected
- Potential adverse affected affected
- No historic effect to historic properties affected properties Construction * ~100 jobs (on average) * ~100 jobs (on average) * ~100 jobs(on average) * ~100 jobs (on average) None Benefits
$2.5M $2.5M $2.5M $2.5M Operation
- SMALL impacts to Impacts resource categories resource categories resource categories resource categories all resource categories Operation * ~125 jobs * ~125 jobs * ~125 jobs * ~125 jobs None Benefits
- Reliable source of 99Mo 99Mo for medical uses for medical uses for medical uses for medical uses
$2.5M $2.5M $2.5M $2.5M 11
Questions?
Exhibit NWMI-007-R 12